TWiV 770: COVID-19 clinical update #67 with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #67, Daniel Griffin reviews antibodies to the virus early in the US, serology testing of blood donations, MIS-C in children under 21, myocarditis in competitive athletes, ER visits for suspected suicide attempts, delta variant in Scotland, Novavax vaccine phase 3 results, vaccine coverage in pregnant women, early monoclonal administration reduces hospitalization and mortality, casirivimab and imdevimab recovery trial results, and CDC guidance on postacute sequelae.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Antiviral antibodies early in US outbreak (CID)
- Serologic testing of US blood donations (CID)
- The virus, what went wrong (PBS)
- MIS-C in children (JAMA)
- Myocarditis in competitive athletes (JAMA)
- ER visits for suspected suicide (MMWR)
- Delta variant in Scotland (Lancet)
- Novavax phase 3 results (Novavax)
- Vaccine coverage in pregnant women (MMWR)
- Early mAb reduces hospitalization and mortality (CID)
- Regen-Cov trial results (Regeneron)
- Guidance on postacute sequelae (CDC)
- Letters read on TWiV 770
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]